Effects of chemotherapeutic agents and immunomodulators on host defense mechanisms: a basis for less empirical chemoimmunotherapy approaches

A. Mantovani, A. Tagliabue, A. Vecchi

Research output: Contribution to journalArticlepeer-review

Abstract

The effect of antineoplastic agents on immune responses is heterogenous. Moreover, the immunomodulators usually employed in experimental and clinical studies seem to act differentially on humoral and cellular immune functions and on the cell-subpopulations involved in these functions. Thus, taking into account the different activities of immunodepressive and immunostimulant agents, a rationale can be developed in drawing experimental immunotherapeutic protocols. The results obtained combining several antineoplastic drugs (Adriamycin, Cyclophosphamide, 5-Fluorouracil, Daunomycin) and several immunomodulators (Corynebacterium parvum, BCG and Levamisole) are summarized. The experimental data show that the best therapeutic activity can be achieved with those combinations (Adriamycin - C. parvum and Cyclophosphamide C. parvum) that were expected to give a synergistic effect from the basic data previously obtained.

Original languageEnglish
Pages (from-to)83-92
Number of pages10
JournalChemioterapia Oncologica
Volume4
Issue number2
Publication statusPublished - 1980

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Effects of chemotherapeutic agents and immunomodulators on host defense mechanisms: a basis for less empirical chemoimmunotherapy approaches'. Together they form a unique fingerprint.

Cite this